EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The influence of ovarian hormones on the putative mechanisms that promote female nicotine use

Priscilla Giner, Sebastian Ortegon, Deniz Bagdas, Laura E O'Dell

Current Opinion in Neurobiology · 2024

DOI: 10.1016/j.conb.2024.102900 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Neurobiology, 2024. Verfasst von Priscilla Giner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, The University of Texas at El Paso, El Paso, TX, 79902, USA. Hauptthemen laut MEDLINE: Nicotine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, U.S. Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotine use is driven by pleasurable effects, but following chronic exposure, nicotine use becomes largely driven by the desire need to avoid withdrawal symptoms. Current cessation strategies focusing on alleviating withdrawal, but current cessation interventions are less effective for women than men. Also, hormone fluctuations across the menstrual cycle appear to impact use patterns, withdrawal severity, and treatment efficacy. This raises important questions regarding optimal quit dates and the application of hormone interventions to alleviate withdrawal in women. This review surveys the existing literature assessing the impact of ovarian hormones on nicotine withdrawal severity. This is an important issue because women seeking cessation treatments may be using hormone-based contraceptives or hormone replacement post-menopause. Hormone interventions may also offer a novel treatment avenue that is more effective than current cessation approaches. Future work in this area is important for reducing health disparities produced by excessive nicotine use in women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineHumansFemaleSubstance Withdrawal SyndromeTobacco Use DisorderOvaryMenstrual CycleSmoking Cessation

Substanzen

Nicotine

Autor:innen und Institutionen

  • Department of Psychology, The University of Texas at El Paso, El Paso, TX, 79902, USA.
  • Department of Psychiatry, Yale School of Medicine, New Haven, CT, 06511, USA; Yale Tobacco Center of Regulatory Science, Yale School of Medicine, New Haven, CT, 06511, USA. Electronic address: deniz.bagdas@yale.edu.
  • Department of Psychology, The University of Texas at El Paso, El Paso, TX, 79902, USA. Electronic address: lodell@utep.edu.

Förderung

  • NIDA NIH HHS
  • NIGMS NIH HHS
  • U.S. Food and Drug Administration
  • NIH

Zitieren

APA

Giner, P., Ortegon, S., Bagdas, D., & O'Dell, L. E. (2024). The influence of ovarian hormones on the putative mechanisms that promote female nicotine use. Current Opinion in Neurobiology. https://doi.org/10.1016/j.conb.2024.102900

Vancouver

Giner P, Ortegon S, Bagdas D, O'Dell LE. The influence of ovarian hormones on the putative mechanisms that promote female nicotine use. Current Opinion in Neurobiology. 2024. doi:10.1016/j.conb.2024.102900

BibTeX
@article{Giner2024,
  author = {Giner, Priscilla and Ortegon, Sebastian and Bagdas, Deniz and O'Dell, Laura E},
  title = {The influence of ovarian hormones on the putative mechanisms that promote female nicotine use},
  journal = {Current Opinion in Neurobiology},
  year = {2024},
  doi = {10.1016/j.conb.2024.102900}
}
Kostenlos starten →